1. Kerlikowske K, Gard CC, Sprague BL, Tice JA, Miglioretti DL; Breast Cancer Surveillance Consortium. One versus two breast density measures to predict 5- and 10-year breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2015; 24:889–97.

2. Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014; 106:dju078.

3. Al Mousa DS, Ryan EA, Mello-Thoms C, Brennan PC. What effect does mammographic breast density have on lesion detection in digital mammography? Clin Radiol. 2014; 69:333–41.

4. Santiago-Rivas M, Benjamin S, Jandorf L. Breast density knowledge and awareness: a review of literature. J Prim Care Community Health. 2016; 7:207–14.
5. Manning MA, Duric N, Littrup P, Bey-Knight L, Penner L, Albrecht TL. Knowledge of breast density and awareness of related breast cancer risk. J Cancer Educ. 2013; 28:270–4.

6. Rhodes DJ, Radecki Breitkopf C, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of breast density and its impact on breast cancer detection and risk. J Clin Oncol. 2015; 33:1143–50.

7. Manning M, Albrecht TL, Yilmaz-Saab Z, Penner L, Norman A, Purrington K. Explaining between-race differences in African-American and European-American women’s responses to breast density notification. Soc Sci Med. 2017; 195:149–58.

8. Santiago-Rivas M, Benjamin S, Andrews JZ, Jandorf L. Breast density awareness and knowledge, and intentions for breast cancer screening in a diverse sample of women age eligible for mammography. J Cancer Educ. 2019; 34:90–7.

9. Ho N, Kim J, Prasad V. Dense breasts and legislating medicine. Cleve Clin J Med. 2013; 80:768–70.

10. Manning M, Albrecht TL, Yilmaz-Saab Z, Shultz J, Purrington K. Influences of race and breast density on related cognitive and emotion outcomes before mandated breast density notification. Soc Sci Med. 2016; 169:171–9.

11. Yeh VM, Schnur JB, Margolies L, Montgomery GH. Dense breast tissue notification: impact on women’s perceived risk, anxiety, and intentions for future breast cancer screening. J Am Coll Radiol. 2015; 12:261–6.

12. Orom H, Kiviniemi MT, Shavers VL, Ross L, Underwood W 3rd. Perceived risk for breast cancer and its relationship to mammography in Blacks, Hispanics, and Whites. J Behav Med. 2013; 36:466–76.

13. Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut AI. Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev. 2004; 13:501–10.
14. Ho SS, Choi KC, Wong CL, Chan CW, Chan HY, Tang WP, et al. Uptake of breast screening and associated factors among Hong Kong women aged ≥50 years: a population-based survey. Public Health. 2014; 128:1009–16.

15. Choi E, Lee YY, Yoon HJ, Lee S, Suh M, Park B, et al. Relationship between cancer worry and stages of adoption for breast cancer screening among Korean women. PLoS One. 2015; 10:e0132351.

16. Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med. 2006; 42:401–8.

17. Robb KA, Miles A, Wardle J. Demographic and psychosocial factors associated with perceived risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13:366–72.
18. Rogers RW, Mewborn CR. Fear appeals and attitude change: effects of a threat’s noxiousness, probability of occurrence, and the efficacy of coping responses. J Pers Soc Psychol. 1976; 34:54–61.

19. Kim Y, Jun JK, Choi KS, Lee HY, Park EC. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev. 2011; 12:725–30.
20. Jo HM, Lee EH, Ko K, Kang BJ, Cha JH, Yi A, et al. Prevalence of women with dense breasts in Korea: results from a nationwide cross-sectional study. Cancer Res Treat. 2019; 51:1295–301.

21. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med. 1991; 114:657–61.

22. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol. 1991; 10:259–67.

23. Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 1997; 6:825–32.
24. McQueen A, Vernon SW, Meissner HI, Rakowski W. Risk perceptions and worry about cancer: does gender make a difference? J Health Commun. 2008; 13:56–79.

25. Shiryazdi SM, Kholasehzadeh G, Neamatzadeh H, Kargar S. Health beliefs and breast cancer screening behaviors among Iranian female health workers. Asian Pac J Cancer Prev. 2014; 15:9817–22.

26. Sak MA, Littrup PJ, Duric N, Mullooly M, Sherman ME, Gierach GL. Current and future methods for measuring breast density: a brief comparative review. Breast Cancer Manag. 2015; 4:209–21.

27. Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, et al. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res. 2014; 16:439.

28. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995; 87:670–5.
